172 related articles for article (PubMed ID: 19073650)
1. Thiazolidinediones: do harms outweigh benefits?
Lipscombe LL
CMAJ; 2009 Jan; 180(1):16-7. PubMed ID: 19073650
[No Abstract] [Full Text] [Related]
2. Thiazolidinedione use and the risk of fractures.
Toulis KA; Goulis DG; Anastasilakis AD
CMAJ; 2009 Apr; 180(8):841-2; author reply 842-3. PubMed ID: 19364796
[No Abstract] [Full Text] [Related]
3. Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis.
Loke YK; Singh S; Furberg CD
CMAJ; 2009 Jan; 180(1):32-9. PubMed ID: 19073651
[TBL] [Abstract][Full Text] [Related]
4. Thiazolidinedione use and the risk of fractures.
Reblin T
CMAJ; 2009 Apr; 180(8):841. PubMed ID: 19364797
[No Abstract] [Full Text] [Related]
5. Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes.
Aubert RE; Herrera V; Chen W; Haffner SM; Pendergrass M
Diabetes Obes Metab; 2010 Aug; 12(8):716-21. PubMed ID: 20590749
[TBL] [Abstract][Full Text] [Related]
6. Rosiglitazone and pioglitazone. Beware fractures.
Dixit A; Pandey P
BMJ; 2009 Sep; 339():b3957. PubMed ID: 19808816
[No Abstract] [Full Text] [Related]
7. [Determining the current position regarding the value of pioglitazone for the therapy of diabetes].
Eckert S; Erdmann E; Lundershausen R; Forst T; Scherbaum WA; Schnell O; Standl E; Schumm-Draeger PM; Tschöpe D; Walter H; Weber M
Dtsch Med Wochenschr; 2007 Dec; 132(49):2650-3. PubMed ID: 18050033
[No Abstract] [Full Text] [Related]
8. Thiazolidinediones and fractures: evidence from translating research into action for diabetes.
Bilik D; McEwen LN; Brown MB; Pomeroy NE; Kim C; Asao K; Crosson JC; Duru OK; Ferrara A; Hsiao VC; Karter AJ; Lee PG; Marrero DG; Selby JV; Subramanian U; Herman WH
J Clin Endocrinol Metab; 2010 Oct; 95(10):4560-5. PubMed ID: 20631021
[TBL] [Abstract][Full Text] [Related]
9. The risk of fractures associated with thiazolidinediones: a self-controlled case-series study.
Douglas IJ; Evans SJ; Pocock S; Smeeth L
PLoS Med; 2009 Sep; 6(9):e1000154. PubMed ID: 19787025
[TBL] [Abstract][Full Text] [Related]
10. The safety of rosiglitazone in the treatment of type 2 diabetes.
Singh S; Loke YK
Expert Opin Drug Saf; 2008 Sep; 7(5):579-85. PubMed ID: 18759710
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes, thiazolidinediones: bad to the bone?
Watts NB; D'Alessio DA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3276-8. PubMed ID: 16960122
[No Abstract] [Full Text] [Related]
12. Diabetes drug pioglitazone (Actos): risk of fracture.
Meymeh RH; Wooltorton E
CMAJ; 2007 Sep; 177(7):723-4. PubMed ID: 17823139
[No Abstract] [Full Text] [Related]
13. Rosiglitazone and pioglitazone in the treatment of diabetes mellitus.
Odom J; Williamson B; Carter L
Am J Health Syst Pharm; 2008 Oct; 65(19):1846-50. PubMed ID: 18796427
[No Abstract] [Full Text] [Related]
14. Safety and efficacy of rosiglitazone in the elderly diabetic patient.
Viljoen A; Sinclair A
Vasc Health Risk Manag; 2009; 5(1):389-95. PubMed ID: 19475776
[TBL] [Abstract][Full Text] [Related]
15. The current role of thiazolidinediones in diabetes management.
Rizos CV; Kei A; Elisaf MS
Arch Toxicol; 2016 Aug; 90(8):1861-81. PubMed ID: 27165418
[TBL] [Abstract][Full Text] [Related]
16. The "glitazones": rosiglitazone and pioglitazone.
Papoushek C
J Obstet Gynaecol Can; 2003 Oct; 25(10):853-7. PubMed ID: 14532954
[TBL] [Abstract][Full Text] [Related]
17. Thiazolidinedione treatment decreases bone mineral density in type 2 diabetic men.
Yaturu S; Bryant B; Jain SK
Diabetes Care; 2007 Jun; 30(6):1574-6. PubMed ID: 17363747
[No Abstract] [Full Text] [Related]
18. Thiazolidinediones: antidiabetic agents with effects on bone.
Debiais F
Joint Bone Spine; 2009 May; 76(3):221-3. PubMed ID: 19362505
[No Abstract] [Full Text] [Related]
19. Type 2 diabetes, thiazolidinediones, and cardiovascular risk.
Taylor C; Hobbs FD
Br J Gen Pract; 2009 Jul; 59(564):520-4. PubMed ID: 19567003
[TBL] [Abstract][Full Text] [Related]
20. Thiazolidinediones.
Mascitelli L; Pezzetta F
N Engl J Med; 2005 Jan; 352(2):205-7; author reply 205-7. PubMed ID: 15651125
[No Abstract] [Full Text] [Related]
[Next] [New Search]
